# Tempest Therapeutics, Inc.: Form 8-K/A, filed Jul 1, 2021

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K/A
- Filed: 2021-07-01
- Accepted by EDGAR: Jul 1, 2021, 16:44 ET
- Period: 2021-06-25
- Accession: 0001193125-21-206427
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000119312521206427/d12343d8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000119312521206427/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000119312521206427/d12343d8ka.htm

Filed Jul 1, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-206427. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
